Lung Cancer Screening Update

Overview

Journal Cancer Imaging

Publisher Springer Nature

Specialties Oncology
Radiology

Date 2009 Dec 8

PMID 19965303

Citations 1

Authors

Massimo Bellomi

Cristiano Rampinelli

Elvio De Fiori

Lorenzo Preda

Giulia Veronesi

Affiliations

Soon will be listed here.

Abstract

Low-dose computed tomography (ld-CT) for lung cancer screening in high-risk subjects is performed within clinical trials and has started to be used in routine clinical practice. The technique is well defined, even if some methodological problems are still debated, such as the measurements of pulmonary nodules, the size to define them as clinically significant, the management of small or non-solid nodules and the best diagnostic work-up to optimize diagnostic accuracy. The data derived from an IEO observational study, started in 2000, shows a high prevalence and incidence of early stage lung cancer detected at ld-CT, demonstrating the need to prolong observation for a long period of time. The high survival rate of patients with screening-detected cancer has recently been debated in a number of papers using statistical models, but the advantage of the yearly ld-CT for the individuals is unquestionable; its benefit on the population base has still to be demonstrated by ongoing randomized trials.

Citing Articles

Screening for lung cancer using low-dose spiral CT: 10 years later, state of the art.

Zompatori M, Mascalchi M, Ciccarese F, Sverzellati N, Pastorino U Radiol Med. 2012; 118(1):51-61.

PMID: 22744348 DOI: 10.1007/s11547-012-0843-5.

References

Jett J . Limitations of screening for lung cancer with low-dose spiral computed tomography. Clin Cancer Res. 2005; 11(13 Pt 2):4988s-4992s. DOI: 10.1158/1078-0432.CCR-05-9000. View

Mayo J, Hartman T, Lee K, Primack S, Vedal S, Muller N . CT of the chest: minimal tube current required for good image quality with the least radiation dose. AJR Am J Roentgenol. 1995; 164(3):603-7. DOI: 10.2214/ajr.164.3.7863879. View

Henschke C, Yankelevitz D, Mirtcheva R, McGuinness G, McCauley D, Miettinen O . CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol. 2002; 178(5):1053-7. DOI: 10.2214/ajr.178.5.1781053. View

Veronesi G, Bellomi M, Scanagatta P, Preda L, Rampinelli C, Guarize J . Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program. J Thorac Cardiovasc Surg. 2008; 136(3):611-7. DOI: 10.1016/j.jtcvs.2008.02.082. View

Flehinger B, Kimmel M, Melamed M . The effect of surgical treatment on survival from early lung cancer. Implications for screening. Chest. 1992; 101(4):1013-8. DOI: 10.1378/chest.101.4.1013. View

Swensen S, Viggiano R, Midthun D, Muller N, Sherrick A, Yamashita K . Lung nodule enhancement at CT: multicenter study. Radiology. 2000; 214(1):73-80. DOI: 10.1148/radiology.214.1.r00ja1473. View

Henschke C, Yankelevitz D, Libby D, Pasmantier M, Smith J, Miettinen O . Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006; 355(17):1763-71. DOI: 10.1056/NEJMoa060476. View

Swensen S, Jett J, Hartman T, Midthun D, Sloan J, Sykes A . Lung cancer screening with CT: Mayo Clinic experience. Radiology. 2003; 226(3):756-61. DOI: 10.1148/radiol.2263020036. View

Schoepf U, Becker C, Obuchowski N, Rust G, Ohnesorge B, Kohl G . Multi-slice computed tomography as a screening tool for colon cancer, lung cancer and coronary artery disease. Eur Radiol. 2001; 11(10):1975-85. DOI: 10.1007/s003300100950. View

10.

Bellomi M, Veronesi G, Rampinelli C, Ferretti S, De Fiori E, Maisonneuve P . Evolution of lung nodules < or =5 mm detected with low-dose CT in asymptomatic smokers. Br J Radiol. 2007; 80(957):708-12. DOI: 10.1259/bjr/46019726. View

11.

Bach P, Jett J, Pastorino U, Tockman M, Swensen S, Begg C . Computed tomography screening and lung cancer outcomes. JAMA. 2007; 297(9):953-61. DOI: 10.1001/jama.297.9.953. View

12.

Gierada D, Pilgram T, Ford M, Fagerstrom R, Church T, Nath H . Lung cancer: interobserver agreement on interpretation of pulmonary findings at low-dose CT screening. Radiology. 2007; 246(1):265-72. DOI: 10.1148/radiol.2461062097. View

13.

Kim H, Shim Y, Lee K, Han J, Yi C, Kim Y . Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons. Radiology. 2007; 245(1):267-75. DOI: 10.1148/radiol.2451061682. View

14.

Christensen J, Nathan M, Mullan B, Hartman T, Swensen S, Lowe V . Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT. AJR Am J Roentgenol. 2006; 187(5):1361-7. DOI: 10.2214/AJR.05.1166. View

15.

Swensen S, Jett J, Hartman T, Midthun D, Mandrekar S, Hillman S . CT screening for lung cancer: five-year prospective experience. Radiology. 2005; 235(1):259-65. DOI: 10.1148/radiol.2351041662. View

16.

Sone S, Takashima S, Li F, Yang Z, Honda T, Maruyama Y . Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet. 1998; 351(9111):1242-5. DOI: 10.1016/S0140-6736(97)08229-9. View

17.

MacMahon H, Austin J, Gamsu G, Herold C, Jett J, Naidich D . Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology. 2005; 237(2):395-400. DOI: 10.1148/radiol.2372041887. View

18.

Ohtsuka T, Nomori H, Horio H, Naruke T, Suemasu K . Radiological examination for peripheral lung cancers and benign nodules less than 10 mm. Lung Cancer. 2003; 42(3):291-6. DOI: 10.1016/s0169-5002(03)00360-x. View

19.

Chien C, Chen T . Mean sojourn time and effectiveness of mortality reduction for lung cancer screening with computed tomography. Int J Cancer. 2008; 122(11):2594-9. DOI: 10.1002/ijc.23413. View

20.

Rampinelli C, De Fiori E, Raimondi S, Veronesi G, Bellomi M . In vivo repeatability of automated volume calculations of small pulmonary nodules with CT. AJR Am J Roentgenol. 2009; 192(6):1657-61. DOI: 10.2214/AJR.08.1825. View